See every side of every news story
Get Started
SubscribeLogin
Israel-Hamas Conflict
Pope Francis
Vatican
Basketball
MLS
Wrestling
Baseball
Hockey
Donald Trump
Elon Musk
Tennis
WWE
Hamas
Published • loading... • Updated

Roflumilast Cream 0.05% Effective for Atopic Dermatitis in Patients Aged 2-5 Years

Summary by hcplive.com
These phase 3 findings from the INTEGUMENT-PED clinical trial highlight the efficacy and safety of roflumilast cream 0.05% for pediatric patients with atopic dermatitis.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

1 Articles

All
Left
Center
Right
hcplive.comhcplive.com

Roflumilast Cream 0.05% Effective for Atopic Dermatitis in Patients Aged 2-5 Years

These phase 3 findings from the INTEGUMENT-PED clinical trial highlight the efficacy and safety of roflumilast cream 0.05% for pediatric patients with atopic dermatitis.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

hcplive.com broke the news in on Saturday, February 22, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

News
For You
Search
BlindspotLocal